Ritonavir is an HIV protease inhibitor that interferes with the reproductive cycle of HIV. Although it was initially developed as an independent antiviral agent, it has been shown to possess advantageous properties in combination regimens with low-dose ritonavir and other protease inhibitors. It is now more commonly used as a booster of other protease inhibi...
Ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
...
AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
AIDS Research Alliance - Chicago, Chicago, Illinois, United States
Baltimore TRIALS, Baltimore, Maryland, United States
Harlem Hosp. Ctr. NY NICHD CRS, New York, New York, United States
The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia, Pennsylvania, United States
HMS - Children's Hosp. Boston, Div. of Infectious Diseases, Boston, Massachusetts, United States
Children's Hospital of Michigan NICHD CRS, Detroit, Michigan, United States
Univ. of Miami Miller School of Medicine - Jackson Memorial Hosp., Miami, Florida, United States
Univ. of Miami Ped. Perinatal HIV/AIDS CRS, Miami, Florida, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.